This is a pilot study to improve rates of germline genetic testing for black patients with aggressive prostate cancer as recommended by the updated guidelines by the National Cancer Comprehensive Network (NCCN) in 2018.
In this study, consented patients will undergo a low-risk intervention of an educational session with a trained staff member on germline testing in prostate cancer and, if agreeable, subsequent germline cancer genetic testing via a commercial lab test.
Men, age greater than or equal to 18 years of age.
Men who racially identify as black or multiracial including black
Diagnosis of prostate cancer of any histology.
Must meet NCCN guidelines for germline testing
Have had prior germline testing.
Have somatic genetic testing that is positive for a possible germline variant.